Natus Medical Announces Entry Into Neurodiagnostic Services Market
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Natus Medical (BABY) Tops Q4 EPS by 1c; Updates FY15 Outlook
January 28, 2015 7:09 AM ESTNatus Medical (NASDAQ: BABY) reported Q4 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $94 million versus the consensus estimate of $93.28 million.
Natus Medical sees Q1 2015 EPS of $0.20-$0.30, versus the consensus of $0.29. Natus Medical sees Q1 2015... More
Natus Medical (BABY) Announces Acquisition of Global Neuro-Diagnostics
January 26, 2015 7:24 AM ESTNatus Medical (Nasdaq: BABY) announced that it has entered the neurodiagnostic services market through the acquisition of Global Neuro-Diagnostics ("GND"). GND was profitable in 2014 with revenue of approximately $7 million.
GND's service offers patients a more convenient way to complete routine video... More
